Senior insider sale
EVP, CFO & CBO at DIANTHUS THERAPEUTICS, INC. /DE/ — senior position signals high conviction
$3.06M
31.25K shares
What this filing means
SAVITZ RYAN plans to sell 31.25K shares of DIANTHUS THERAPEUTICS, INC. /DE/ valued at approximately $3.06M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/9/2026ACC: 0001950047-26-006986
Officer· EVP, CFO & CBO
Since Feb 2026
31.25K
Shares to sell
$3.06M
Approx. market value
31.25K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
7/9/2026
31.25KTotal acquired31.25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/9/2026 | Exercise of Stock Options Cash | 31.25K | — |
| Total | 31.25K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
31.25K
Market value
$3.06M
7/9/2026
Total
Units
31.25K
Value
$3.06M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/9/2026 | 31.25K | $3.06M | NASDAQ | Planned |
| Total | 31.25K | $3.06M | ||